首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1735620

全球疫苗注射裝置市場規模（按設備、給藥途徑、最終用戶、區域覆蓋範圍和預測）

Global Vaccine Delivery Devices Market Size By Devices, By Route Of Administration, By End-User, By Geographic Scope And Forecast

出版日期: 2025年05月02日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

疫苗輸送裝置市場規模及預測

2024 年疫苗輸送裝置市場規模價值 49.9 億美元，預計到 2032 年將達到 88.3 億美元，2026 年至 2032 年的複合年成長率為 8.5%。

疫苗輸送裝置是專門為疫苗接種而設計的工具和技術。這些裝置對於醫護人員和個人至關重要，可確保精準劑量、安全輸送以及有效預防感染疾病。
疫苗接種裝置通常用於醫院、診所和醫生辦公室等醫療機構的常規免疫計劃，包括兒童疫苗接種計劃、季節性流感疫苗接種宣傳活動和其他預防性健康舉措。
疫苗接種單位在社區健康計畫和推廣工作中發揮著至關重要的作用，特別是在醫療服務有限的農村和服務不足地區。
無針注射是最新的疫苗注射技術之一，已在大規模疫苗接種計劃中得到有效應用，有助於減少針刺傷的機會以及因多次使用一根針而引起的併發症。
此外，其他疫苗輸送裝置包括噴射注射器、一次性注射器、微針和皮內輸送裝置，所有這些裝置都用於輸送去活化脊髓灰質炎疫苗。

疫苗輸送裝置的全球市場動態

影響疫苗輸送設備市場的關鍵市場動態是：

關鍵市場促進因素

強大的研發實力：全球產品供應的不斷成長，促進了旨在消除地方病的疫苗接種計劃市場的成長。各國政府、醫院和製藥公司正在推廣定期且負擔得起的疫苗接種，積極的政府監督也確保每個人都能以最低的成本接種疫苗。
提高醫療保健領域的疫苗接種覆蓋率：疫苗接種設備的需求源於擴大疫苗接種覆蓋率和覆蓋服務不足人群的努力，各國政府、醫療保健組織和非政府組織正在合作提高中低收入國家的免疫接種率。
政府醫療保健支出的增加：疫苗接種設備的需求受到政府主導的努力的推動，這些努力旨在提高疫苗接種覆蓋率並向服務不足的人群提供疫苗，這得益於醫療保健組織和非政府組織之間的合作。
技術進步：由於針刺傷、受污染針頭導致的感染疾病以及針頭消毒不當導致的血源性感染疾病的風險，無針輸送裝置的需求正在蓬勃發展。主要企業、國際組織和研究機構對新型輸送技術的興趣正在推動市場成長。
例如，2022年1月，輝瑞與Acuitas Therapeutics合作開發了一種專為mRNA疫苗和療法設計的脂質奈米顆粒遞送系統。此次合作旨在利用兩家公司的專業知識，提高基於mRNA的療法和疫苗的遞送效率和療效。

主要挑戰

疫苗接種成本高昂：慢性病和感染疾病的日益普及推動了市場的成長。然而，每劑疫苗的高昂成本阻礙了市場的擴張。儘管國際組織已向全球提供了數百萬劑疫苗，但由於成本高昂，許多地區仍未接種疫苗。
基礎設施挑戰：疫苗供應鏈需要嚴格的溫度控制才能維持效力。在低溫運輸基礎設施薄弱的地區，例如農村和偏遠地區，這可能難以實現，這可能會損害疫苗效力並減少對疫苗供應設備的需求。
醫療保健人員能力挑戰：缺乏訓練有素的醫療保健人員可能會影響疫苗的正確管理，導致管理延遲、管理錯誤和輸送設備處理不當，即使有合適的輸送設備，也會影響整體疫苗接種結果。
疫苗供應鏈中斷：供應鏈中斷，包括生產延誤、配送瓶頸和物流挑戰，可能會影響疫苗配送設備的供應和可及性。自然災害、地緣政治緊張局勢和突發公共衛生事件造成的供應鏈中斷可能會擾亂疫苗接種計劃，並限制疫苗配送設備的部署。

主要趨勢：

無痛接種：為了提高病患的舒適度和接受度，人們對開發無痛疫苗接種方法的興趣日益濃厚。微針貼片等技術可以透過侵入性較小、疼痛較小的皮膚穿刺來遞送疫苗，可能比傳統的針頭接種方法更具優勢，尤其是在兒童和老年人群體中。
智慧注射器：將數位健康技術融入疫苗傳輸設備，例如配備感測器和連接功能的智慧注射器，將能夠即時監測疫苗接種情況、追蹤劑量並確保疫苗接種計畫的執行。這些設備將有助於數據收集，增強患者參與度，並支援遠端患者監護。
生物分解性和環保材料：隨著人們日益重視永續性和環境責任，疫苗輸送裝置正採用生物分解性和環保材料製造。製造商正在探索傳統塑膠的替代品，例如生質塑膠和可堆肥材料，以減少其對環境的影響並推廣循環經濟原則。

Vaccine delivery devices are tools and technologies specifically designed for the administration of vaccines. These devices are essential for healthcare professionals and individuals to ensure accurate dosage, safe delivery, and proper immunization against infectious diseases.
Vaccine delivery devices are commonly used in healthcare facilities such as hospitals, clinics, and medical offices for routine immunization programs, including childhood vaccination schedules, seasonal flu vaccination campaigns, and other preventive healthcare initiatives.
Vaccine delivery devices play a crucial role in community health programs and outreach efforts, particularly in rural or underserved areas where access to healthcare services may be limited.
One of the latest vaccine delivery technologies, such as needle-free options, is effectively used in mass immunization programs. It helps to reduce the chances of needle stick injuries and the complications associated with the multiple uses of a single needle.
Moreover, other vaccine delivery devices include jet injectors, disposable syringes, microneedles, and intradermal delivery devices. These are all used for the delivery of inactivated poliovirus vaccines.

Global Vaccine Delivery Devices Market Dynamics

The key market dynamics that are shaping the Vaccine Delivery Devices Market include:

Key Market Drivers:

Robust Research and Development: The global increase in product supply is facilitating market expansion for vaccination programs aimed at eradicating endemic diseases. Governments, hospitals, and pharmaceutical corporations are promoting routine and affordable vaccinations, with active government surveillance ensuring everyone receives them at minimal cost.
Expanded Immunization Coverage in Healthcare Sector: The demand for vaccine delivery devices is driven by efforts to expand immunization coverage and reach underserved populations, with collaboration between governments, healthcare organizations, and NGOs aiming to improve vaccination rates in low- and middle-income countries.
Rising Healthcare Expenditure by Government: The demand for vaccine delivery devices is fueled by government-led initiatives to enhance immunization coverage and reach underserved populations, facilitated by collaborations between healthcare organizations and NGOs.
Technological Advancements: The demand for needle-free delivery is surging due to the risks of needle stick injuries, infection from contaminated needles, and blood-borne infections from improperly sterilized needles. The market growth is expected to be driven by interest from key players, international organizations, and institutions in novel delivery technologies.
For instance, in January 2022, Pfizer Inc. and Acuitas Therapeutics joined forces to develop a lipid nanoparticle delivery system that is specifically designed for mRNA vaccines and therapeutics. This collaboration aims to leverage the expertise of both companies to enhance the delivery efficiency and effectiveness of mRNA-based treatments and vaccines.

Key Challenges:

High Costs of Vaccine Dose: The growing incidence of chronic and infectious diseases is driving market growth. However, high costs associated with the per-dose vaccine volume are hampering market expansion. Though international organizations are supplying millions of volume doses around the globe, many parts are yet to receive vaccination due to their high cost.
Infrastructure Challenges: The supply chain of vaccines requires strict temperature control to maintain their potency. In regions with inadequate cold chain infrastructure, such as rural or remote areas, this becomes challenging, potentially compromising vaccine effectiveness and decreasing demand for vaccine delivery devices.
Healthcare Workforce Capacity Challenges: A shortage of trained healthcare workers is hindering the proper administration of vaccines, leading to delays, dosage errors, and improper handling of delivery devices, affecting overall immunization outcomes, even with adequate delivery devices available.
Disruptions in the Vaccine Supply Chain: Supply chain disruption such as manufacturing delays, distribution bottlenecks, and logistics challenges, is likely to impact the availability and accessibility of vaccine delivery devices. Supply chain disruptions, whether due to natural disasters, geopolitical tensions, or public health emergencies, may disrupt immunization programs and limit the deployment of vaccine delivery devices.

Key Trends:

Painless Administration: There is growing interest in developing painless vaccine delivery methods to enhance patient comfort and acceptance. Technologies such as microneedle patches, which deliver vaccines through painless, minimally invasive skin punctures, offer potential advantages over traditional needle-based injections, particularly for pediatric and geriatric populations.
Smart Injection Devices: Integration of digital health technologies into vaccine delivery devices, such as smart injection devices equipped with sensors and connectivity features, allows for real-time monitoring of vaccination administration, dosage tracking, and adherence to vaccination schedules. These devices facilitate data collection, enhance patient engagement, and support remote patient monitoring.
Biodegradable and Eco-Friendly Materials: Increasing emphasis on sustainability and environmental responsibility drives the adoption of biodegradable and eco-friendly materials in vaccine delivery devices. Manufacturers are exploring alternatives to conventional plastics, such as bioplastics and compostable materials, to reduce environmental impact and promote circular economy principles.

Global Vaccine Delivery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Vaccine Delivery Devices Market:

North America:

North America has established regulatory frameworks for healthcare products, including vaccine delivery devices, overseen by agencies like the FDA and Health Canada. These standards ensure safety, efficacy, and quality, boosting consumer confidence and market growth.
The region is at the forefront of technological innovation in healthcare, including vaccine delivery devices. Advancements such as needle-free injectors, auto-disable syringes, and smart injection devices improve vaccine administration, enhance patient comfort, and optimize immunization outcomes.
North America is home to several key market players, including pharmaceutical companies, medical device manufacturers, and healthcare technology firms. These companies drive innovation, research, and development in vaccine delivery devices, introducing new products and technologies to the market.

Europe:

Europe places a strong emphasis on healthcare quality and safety, driving the adoption of advanced healthcare technologies and best practices. Vaccine delivery devices must meet high standards of safety, reliability, and performance to ensure patient well-being and public health outcomes.
European governments provide support for vaccination programs through funding, policy development, and public health campaigns. National vaccination schedules, recommendations, and incentives encourage vaccination uptake and drive demand for vaccine delivery devices across healthcare settings.
European countries continue to invest in healthcare infrastructure, research and development, and innovation to improve healthcare delivery and patient outcomes. Investments in vaccination programs, including the procurement of vaccine delivery devices, contribute to market growth and innovation in the region.

Asia Pacific:

Asia Pacific is home to some of the world's most populous countries, including China and India. The sheer size of the population creates a substantial demand for vaccines and vaccine delivery devices to address healthcare needs.
Economic growth in many countries across the Asia Pacific region has led to increased healthcare spending. Governments and private sectors are investing more in healthcare infrastructure, including vaccination programs and the procurement of vaccine delivery devices.
There is a growing awareness among individuals and communities in the Asia Pacific about the importance of preventive healthcare measures, including vaccination. Public health campaigns, educational initiatives, and advocacy efforts contribute to increased vaccination uptake and demand for vaccine-delivery devices.
Emerging economies in Asia Pacific, such as China, India, Indonesia, and Vietnam, offer significant growth opportunities due to their large populations and increasing investments in healthcare infrastructure. These countries are witnessing rapid urbanization, economic development, and healthcare reforms, driving demand for healthcare products and services, including vaccine delivery devices.

Global Vaccine Delivery Devices Market: Segmentation Analysis

The Global Medical Sensors Market is Segmented on the basis of Devices, Route Of Administration, End-User, And Geography.

Vaccine Delivery Devices Market, By Devices

Syringes
Jet Injectors

Based on Devices, The market is segmented into Syringes and Jet Injectors. Among these, syringes are expected to dominate the market as they provide flexibility in administering various vaccinations, including liquid and lyophilized vaccines (which are freeze-dried and need to be reconstituted before use). Syringes can be used in various immunization situations. However, the jet injectors segment of the Vaccine Delivery Devices Market is expanding at the quickest rate.

Vaccine Delivery Devices Market, By Route Of Administration

Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination

Based on Route Of Administration, The market is segmented into Intradermal, Intramuscular, and Subcutaneous. The largest market segment is intradermal, which enhances immunogenicity by interacting directly with skin-derived immune cells. Intramuscular, the most rapidly growing segment, is recommended for administering a wide range of vaccinations, booster shots, and routine immunizations to individuals of all ages due to its versatility.

Vaccine Delivery Devices Market, By End-User

Hospitals & Clinics
Home Care Settings
Ambulatory Surgery Centers

Based on End-User, The market is segmented into Hospitals & clinics, Home Care Settings, and Ambulatory Surgery Centers. Hospitals typically account for the majority share in the end-user segment of the Vaccine Delivery Devices Market. Hospitals often serve as centralized hubs for vaccination services, providing a wide range of vaccines to patients across various age groups and medical conditions. Academic medical centers and research hospitals play a key role in vaccine research, clinical trials, and medical education. They utilize vaccine delivery devices for research purposes, vaccine trials, and training healthcare professionals.

Key Players

The "Global Vaccine Delivery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are 3M, Becton Dickinson & Company, Gerresheimer AG, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.), SCHOTT AG, Valeritas, PharmaJet, Vaxxas, and Corium International, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Vaccine Delivery Devices Market, Recent Developments
In March 2022, The National Institute of Allergy and Infectious Diseases (NIAID) initiated a clinical trial to evaluate three experimental HIV vaccines. These vaccines are developed using a messenger RNA (mRNA) platform, which has been previously used in multiple Covid-19 vaccines that have been approved.
In April 2023, the FDA approved CSL's immunoglobulin pre-filled syringe, Hizentra, for use in treating patients with chronic inflammatory demyelinating conditions. Primary Immunodeficiency (PI) and Polyneuropathy (CIDP). The injection offers convenient drug delivery and is ready for use.

1 INTRODUCTION OF GLOBAL VACCINE DELIVERY DEVICES MARKET

1.1 Introduction of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL VACCINE DELIVERY DEVICES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY DEVICES

5.1 Overview
5.2 Syringes
5.3 Jet Injectors

6 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION

6.1 Overview
6.2 Intradermal Vaccination
6.3 Intramuscular Vaccination
6.4 Subcutaneous Vaccination

7 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY END-USER

7.1 Overview
7.2 Hospitals & Clinics
7.3 Home Care Settings
7.4 Ambulatory Surgery Centers

8 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL VACCINE DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 3M
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Becton Dickinson & Company
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Gerresheimer AG
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 SCHOTT AG
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Valeritas
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 PharmaJet
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Vaxxas
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Corium International, Inc
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments